Updated 25/05/2026
The South African Health Products Regulatory Authority (SAHPRA) has launched a comprehensive digital training programme to strengthen medicine and vaccine safety reporting across Mpumalanga province. The two-day workshop in Mbombela, held from 24-25 February 2026, equipped healthcare workers with practical skills in electronic adverse event reporting systems.
Healthcare Worker Training Initiatives Across South African Provinces
Number of digital safety reporting workshops conducted by SAHPRA, 2025-2026
Source: SAHPRA Training Records, 2026 | Georgian Medical Journal News
Digital transformation in pharmacovigilance
The training programme focused on practical implementation of electronic reporting tools for adverse drug reactions and vaccine-related events. Healthcare workers received hands-on instruction in navigating digital platforms that streamline safety data collection and submission to World Health Organization databases.
SAHPRA’s initiative aligns with global pharmacovigilance standards established by the WHO Programme for International Drug Monitoring. The electronic systems enable real-time reporting and faster signal detection for potential safety concerns.
Recent updates to clinical reporting frameworks emphasise the critical role of frontline healthcare workers in identifying and documenting adverse events.
Strengthening provincial healthcare capacity
The Mbombela workshop targeted healthcare professionals from public and private facilities across Mpumalanga province. Participants included pharmacists, nurses, and physicians working in primary care, hospital settings, and specialised treatment centres.
Training modules covered electronic case report form completion, severity assessment protocols, and causality evaluation methods recommended by the European Medicines Agency. Special emphasis was placed on vaccine safety monitoring following South Africa’s expanded immunisation programme.
The programme builds on quality improvement initiatives that have enhanced medication safety reporting rates in provinces with established digital systems.
Impact on patient safety outcomes
Electronic reporting systems enable healthcare facilities to track adverse event patterns more effectively than paper-based methods. The digital platforms provide automated alerts for serious adverse reactions and facilitate rapid communication with regulatory authorities.
Integration with existing hospital information systems allows for seamless documentation and follow-up of safety events. Healthcare workers can access patient medication histories and previous adverse reaction records directly through the reporting interface.
Data published by the US Food and Drug Administration demonstrate that electronic pharmacovigilance systems improve reporting completeness compared to traditional methods.
Key takeaways
- SAHPRA conducted 2-day intensive training on electronic medicine safety reporting in Mpumalanga province
- Digital systems improve adverse event reporting completeness compared to paper methods
- Training programme aligns with WHO international pharmacovigilance standards for real-time safety monitoring
Frequently asked questions
What types of adverse events should healthcare workers report electronically?
Healthcare workers should report all suspected adverse drug reactions, vaccine-related events, medication errors, and quality defects using electronic systems. This includes both serious and non-serious events that may be related to medical products.
How quickly must adverse events be reported through digital platforms?
Serious adverse events require immediate reporting through electronic systems. Non-serious events should also be documented to maintain comprehensive safety databases.
Will electronic reporting systems integrate with existing hospital records?
Yes, SAHPRA’s electronic platforms are designed to integrate with hospital information systems and electronic health records. This enables seamless access to patient medication histories and automated safety alerts.
SAHPRA plans to expand digital training programmes to remaining provinces throughout 2026, with particular focus on rural healthcare facilities where electronic reporting adoption remains limited. The regulatory authority aims to establish comprehensive nationwide coverage of digital pharmacovigilance systems by early 2027, supporting South Africa’s commitment to international medicine safety standards.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
